• Je něco špatně v tomto záznamu ?

Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions

D. Lukovic, A. Diez Lloret, P. Stojkovic, D. Rodríguez-Martínez, MA. Perez Arago, FJ. Rodriguez-Jimenez, P. González-Rodríguez, J. López-Barneo, E. Sykova, P. Jendelova, J. Kostic, V. Moreno-Manzano, M. Stojkovic, SS. Bhattacharya, S. Erceg,

. 2017 ; 6 (4) : 1217-1226. [pub] 20170218

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028805

Neural differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) can produce a valuable and robust source of human neural cell subtypes, holding great promise for the study of neurogenesis and development, and for treating neurological diseases. However, current hESCs and hiPSCs neural differentiation protocols require either animal factors or embryoid body formation, which decreases efficiency and yield, and strongly limits medical applications. Here we develop a simple, animal-free protocol for neural conversion of both hESCs and hiPSCs in adherent culture conditions. A simple medium formula including insulin induces the direct conversion of >98% of hESCs and hiPSCs into expandable, transplantable, and functional neural progenitors with neural rosette characteristics. Further differentiation of neural progenitors into dopaminergic and spinal motoneurons as well as astrocytes and oligodendrocytes indicates that these neural progenitors retain responsiveness to instructive cues revealing the robust applicability of the protocol in the treatment of different neurodegenerative diseases. The fact that this protocol includes animal-free medium and human extracellular matrix components avoiding embryoid bodies makes this protocol suitable for the use in clinic. Stem Cells Translational Medicine 2017;6:1217-1226.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028805
003      
CZ-PrNML
005      
20190822104718.0
007      
ta
008      
190813s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/sctm.16-0371 $2 doi
035    __
$a (PubMed)28213969
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Lukovic, Dunja $u Stem Cells Therapies in Neurodegenerative Diseases Lab. National Stem Cell Bank-Valencia Node, Biomolecular and Bioinformatics Resources Platform PRB2,ISCIII.
245    10
$a Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions / $c D. Lukovic, A. Diez Lloret, P. Stojkovic, D. Rodríguez-Martínez, MA. Perez Arago, FJ. Rodriguez-Jimenez, P. González-Rodríguez, J. López-Barneo, E. Sykova, P. Jendelova, J. Kostic, V. Moreno-Manzano, M. Stojkovic, SS. Bhattacharya, S. Erceg,
520    9_
$a Neural differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) can produce a valuable and robust source of human neural cell subtypes, holding great promise for the study of neurogenesis and development, and for treating neurological diseases. However, current hESCs and hiPSCs neural differentiation protocols require either animal factors or embryoid body formation, which decreases efficiency and yield, and strongly limits medical applications. Here we develop a simple, animal-free protocol for neural conversion of both hESCs and hiPSCs in adherent culture conditions. A simple medium formula including insulin induces the direct conversion of >98% of hESCs and hiPSCs into expandable, transplantable, and functional neural progenitors with neural rosette characteristics. Further differentiation of neural progenitors into dopaminergic and spinal motoneurons as well as astrocytes and oligodendrocytes indicates that these neural progenitors retain responsiveness to instructive cues revealing the robust applicability of the protocol in the treatment of different neurodegenerative diseases. The fact that this protocol includes animal-free medium and human extracellular matrix components avoiding embryoid bodies makes this protocol suitable for the use in clinic. Stem Cells Translational Medicine 2017;6:1217-1226.
650    _2
$a buněčná diferenciace $x fyziologie $7 D002454
650    _2
$a buněčná a tkáňová terapie $7 D064987
650    _2
$a kultivované buňky $7 D002478
650    _2
$a embryonální kmenové buňky $x fyziologie $7 D053595
650    _2
$a lidé $7 D006801
650    _2
$a indukované pluripotentní kmenové buňky $x cytologie $7 D057026
650    _2
$a pluripotentní kmenové buňky $x cytologie $7 D039904
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Diez Lloret, Andrea $u CABIMER (Centro Andaluz de Biología Molecular y Medicina Regenerativa), Avda. Americo Vespucio s/n, Parque Científico y Tecnológico Cartuja, Sevilla, Spain.
700    1_
$a Stojkovic, Petra $u Spebo Medical, Leskovac, Serbia.
700    1_
$a Rodríguez-Martínez, Daniel $u CABIMER (Centro Andaluz de Biología Molecular y Medicina Regenerativa), Avda. Americo Vespucio s/n, Parque Científico y Tecnológico Cartuja, Sevilla, Spain.
700    1_
$a Perez Arago, Maria Amparo $u Stem Cells Therapies in Neurodegenerative Diseases Lab.
700    1_
$a Rodriguez-Jimenez, Francisco Javier $u Stem Cells Therapies in Neurodegenerative Diseases Lab.
700    1_
$a González-Rodríguez, Patricia $u Instituto de Biomedicina de Sevilla (IBiS) and Departamento de Fisiología Médica y Biofísica, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
700    1_
$a López-Barneo, José $u Instituto de Biomedicina de Sevilla (IBiS) and Departamento de Fisiología Médica y Biofísica, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
700    1_
$a Sykova, Eva $u Department of Neuroscience, Institute of Experimental Medicine, Academy of Science of the Czech Republic, Prague, Czech Republic.
700    1_
$a Jendelova, Pavla $u Department of Neuroscience, Institute of Experimental Medicine, Academy of Science of the Czech Republic, Prague, Czech Republic.
700    1_
$a Kostic, Jelena $u Stem Cells Therapies in Neurodegenerative Diseases Lab.
700    1_
$a Moreno-Manzano, Victoria $u Neuronal And Tissue Regeneration Lab, Research Center "Principe Felipe", Valencia, Spain.
700    1_
$a Stojkovic, Miodrag $u Spebo Medical, Leskovac, Serbia. Faculty of Medical Sciences, Human Genetics Department, University of Kragujevac, Serbia.
700    1_
$a Bhattacharya, Shomi S $u CABIMER (Centro Andaluz de Biología Molecular y Medicina Regenerativa), Avda. Americo Vespucio s/n, Parque Científico y Tecnológico Cartuja, Sevilla, Spain.
700    1_
$a Erceg, Slaven $u Stem Cells Therapies in Neurodegenerative Diseases Lab. National Stem Cell Bank-Valencia Node, Biomolecular and Bioinformatics Resources Platform PRB2,ISCIII. Department of Neuroscience, Institute of Experimental Medicine, Academy of Science of the Czech Republic, Prague, Czech Republic.
773    0_
$w MED00181744 $t Stem cells translational medicine $x 2157-6564 $g Roč. 6, č. 4 (2017), s. 1217-1226
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28213969 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822104957 $b ABA008
999    __
$a ok $b bmc $g 1433954 $s 1067265
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 6 $c 4 $d 1217-1226 $e 20170218 $i 2157-6564 $m Stem cells translational medicine $n Stem Cells Transl Med $x MED00181744
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

    Možnosti archivace